Abuse Deterrent Pharma, LLC 3
3 · ACURA PHARMACEUTICALS, INC · Filed Aug 7, 2019
Insider Transaction Report
Form 3
Abuse Deterrent Pharma, LLC
10% Owner
Holdings
Convertible Promissory Note
Exercise: $0.16From: 2019-06-28→ Common Stock (37,500,000 underlying)Warrant
Exercise: $0.01From: 2019-06-28Exp: 2024-06-28→ Common Stock (10,000,000 underlying)
Footnotes (2)
- [F1]The note is convertible, at the election of the Reporting Person, at any time prior to repayment of the Note and matures on July 1, 2023.
- [F2]Excludes any interest accruing on the Note, which is convertible at the election of the Reporting Person.